Problem statement: Answer the multiple-choice question.
Query: Which drug has a 8.145% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) O=C1Nc2c(ccc(Cl)c2Cl)C(=O)C1(F)c1ccccc1
b.) O=C(CSc1nc2ncccc2[nH]1)Nc1ccc2c(c1)OCCO2
c.) CC(C)c1ccc(C(=O)OC2CCOC2=O)cc1
Answer: c. CC(C)c1ccc(C(=O)OC2CCOC2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)c1ccc(C(=O)OC2CCOC2=O)cc1
CC(C)c1ccc(C(=O)OC2CCOC2=O)cc1
(2-oxooxolan-3-yl) 4-propan-2-ylbenzoate